Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho's Jared Holz
0
0
30/08/24
Dans
Amérique du Nord / États-Unis
Jared Holz, Mizuho, joins 'Fast Money' to talk opportunities in pharma investing following approval of Emergent Bio's Mpox vaccine.
Montre plus
0 commentaires
sort Trier par
